Anthracycline-containing versus carboplatin-containing neoadjuvant chemotherapy in combination with trastuzumab for HER2-positive breast cancer: the neoCARH phase II randomized clinical trial.
Hong-Fei GaoZhiyong WuYing LinXiang-Yang SongYin CaoQian-Jun ChenGangling ZhangPeifen FuZhenzhen LiuLiu-Lu ZhangCi-Qiu YangMei YangTeng ZhuFei JiJie-Qing LiMin-Yi ChengKun WangPublished in: Therapeutic advances in medical oncology (2021)
This trial was registered with ClinicalTrials.gov identifier: NCT03140553) on 2 May 2017.
Keyphrases
- phase ii
- neoadjuvant chemotherapy
- positive breast cancer
- phase iii
- open label
- clinical trial
- double blind
- phase ii study
- locally advanced
- placebo controlled
- lymph node
- sentinel lymph node
- epidermal growth factor receptor
- rectal cancer
- study protocol
- metastatic breast cancer
- squamous cell carcinoma
- randomized controlled trial
- radiation therapy